Haas, Wolfgang <br/><br/>
Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin.  [electronic resource] 

 -  Advances in therapy  May 2012 
 - 442-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-012-0023-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Ophthalmic<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Azepines--administration & dosage<br/>Bacteria--classification<br/>Bacteriological Techniques<br/>Child<br/>Child, Preschool<br/>Clinical Trials as Topic<br/>Conjunctivitis, Bacterial--drug therapy<br/>Drug Administration Schedule<br/>Drug Resistance, Bacterial<br/>Female<br/>Fluoroquinolones--administration & dosage<br/>Humans<br/>Infant<br/>Male<br/>Middle Aged<br/>Young Adult